Senior insider sale
President and CEO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$1.51M
3.24K shares
What this filing means
SIBOLD WILLIAM JOHN plans to sell 3.24K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $1.51M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/6/2026ACC: 0001628280-26-015767
DirectorOfficer· President and CEO
Since Mar 2026
3.24K
Shares to sell
$1.51M
Approx. market value
1.66K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
3/5/2026
1.66KTotal acquired1.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 1.66K | — |
| Total | 1.66K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.58K
Market value
$776.5K
1/26/2026
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
1.66K
Market value
$730.6K
3/6/2026
Total
Units
3.24K
Value
$1.51M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 1.58K | $776.5K | — | Completed |
| Planned — Approximate Date | ||||
3/6/2026 | 1.66K | $730.6K | Nasdaq Stock Market | Planned |
| Total | 3.24K | $1.51M | ||